V-Bio Ventures

About The Fund

V-Bio Ventures is a life science Venture Capital fund based in Gent, Belgium, focused on leveraging great science and empowering talented entrepreneurs to build exceptional companies. With €186 million funds under management across two funds, they target early- to mid-stage investments and have a thematic focus on therapeutics. Their investment strategy revolves around sourcing innovative and transformational technologies, with a preference for private companies bringing forth differentiated technology that addresses unmet societal or environmental needs. V-Bio Ventures' investment criteria emphasize therapeutics, including drug discovery and development, and they source deals from research institutes, entrepreneurial initiatives, or spin-outs from mature companies, mainly focusing on Europe. They have a preferred relationship with the VIB, one of the world's leading life science research institutes, for co-creating startups based on VIB-derived innovations. Their investor base is diverse, including financial institutions, governmental bodies, family offices, and academic institutions, with funds supported in part by InnovFin Equity, backed by the European Union. The team at V-Bio Ventures consists of experts with deep experience in life sciences, venture capital, and biopharmaceutical industries. They actively manage investments with an equity expertise and provide hands-on support to entrepreneurs, often being part of the foundational structure of the companies they back. The fund targets investments ranging from €250,000 to €2,000,000, aiming to guide companies from breakthrough ideas to global healthcare solutions. V-Bio Ventures is not just about investing capital; it's about a collaborative journey to positively impact human health and society.